Keio University

Press Release

201-210 items (total 1561)
Published At September 30, 2024

Successful Control of Orbital Current Conduction—A New Discovery Leading to the Accelerated Evolution of Electronic Technology

Published At September 30, 2024

HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Receives Its First Regulatory Approval― HemeSight® hematological malignancies gene panel test approved in Japan

Published At September 27, 2024

Novel Treatment for Drug-Resistant Bacteria and Inflammatory Bowel Disease Using Gut Microbiota: Suppression of Enterobacteriaceae by Controlling the Gut Environment

Published At September 25, 2024

"COVID-19 Task Force" – Large-Scale Identification of Human Genomic Sequences Contributing to Individual Differences in Plasma Protein Levels

Published At September 25, 2024

Effectiveness of Robot-Assisted Preventive Care Program Revealed—33% Increase in Normal Walking Speed

Published At September 24, 2024

Regarding the Manufacturing and Marketing Approval of Hemsite®, Japan's First Gene Panel Test for Hematologic Malignancies

Published At September 24, 2024

Discovery of Nuclear Envelope and Nuclear Pore Complex Defects as a Novel Therapeutic Target for Amyotrophic Lateral Sclerosis (ALS) - Uncovering Pathophysiological Clues from Genome-Edited Mice, iPS Cells, and Pathological Samples

Published At September 24, 2024

Keio University Collaborates with Carnegie Mellon University and Industry to Establish a Research Center to Lead Next-Generation AI

Published At September 24, 2024

Additional Rest After Subjective Sickness Subsides Leads to Sickness Reduction—Hopes for Efficient Simulator Sickness Reduction—

Published At September 20, 2024

Successful Transmission Experiment in a Proof-of-Concept Study for Next-Generation In-Vehicle Optical Communication Systems—High-Speed In-Vehicle Optical Communication Systems to Support Fully Autonomous Driving—